BABA vs REGN · P/E 20, rev $137.30B vs P/E 14, rev $14.34B
Alibaba Group Holding Ltd (BABA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BABA and REGN stock pages for the full models.
Not investment advice.